Medtronic (NYSE:MDT) announced today that it exercised its option to acquire coronary artery disease (CAD) tech developer ...
Medtronic (NYSE: MDT) intends to exercise its option to acquire CathWorks and its coronary artery disease treatment platform.
Medtronic expands cath lab tools by acquiring CathWorks for $585 million, enhancing its interventional cardiology portfolio with AI technology.
The purchase will give Medtronic a larger presence in the cath lab, with a tool to help diagnose and treat coronary artery ...
Medtronic is expanding its presence in the cath lab market with its latest acquisition. The Dublin-based company announced it ...
CathWorks, a global leader in digital health innovations, announced that the Society for Cardiovascular Angiography & Interventions (SCAI) published an expert opinion discussing the expanding role of ...
Vietnam Investment Review on MSN
SCAI endorses CathWorks FFRangio technology
NEWPORT BEACH, Calif., Feb. 4, 2026 /PRNewswire/ -- CathWorks, a global leader in digital health innovations, announced that the Society for Cardiovascular Angiography & Interventions (SCAI) published ...
Background International guidelines recommend percutaneous coronary intervention within 120 min for high-risk acute coronary syndrome. In Indonesia, a sprawling archipelago with a rising ...
Sponsored by Baton Rouge General During a heart attack, every minute counts. Permanent heart damage can begin in as little as ...
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...
MedPage Today on MSN
Body Roundness Index; In-Hospital STEMI Care Delays; Income and Cardiac Arrest
Recent developments of interest in cardiovascular medicine ...
The strategic option to buy was signed in 2022. As part of the option, Medtronic invested $75 million in CathWorks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results